• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of meetings held in the quarter

Dictionary: Each year, FDA review staffs participate in meetings with sponsors and applicants who seek guidance relating to the development and review of investigational new drugs and biologics, and drug or biological product marketing applications. These measures focus on the timeliness of providing written responses to pre-meeting questions that are submitted by sponsors before a scheduled face-to-face meeting. The Center’s goal is to provide comprehensive responses prior to the meeting to further advance the exchange of information leading to more efficient product development.

Information is current as of December 31, 2014

Fiscal Year - 2015

Skip graphic and jump to text data

TimeTargetNumber
October – December 2014N/A67
January – March 2015N/ATBD
April – June 2015N/ATBD
July – September 2015N/ATBD

FY 2015 YTD: 67

Number of meetings cancelled by the requestor in the quarter because written feedback was provided prior to the scheduled meeting

Fiscal Year - 2015

Skip graphic and jump to text data

TimeTargetNumber
October – December 2014N/A18
January – March 2015N/ATBD
April – June 2015N/ATBD
July – September 2015N/ATBD

FY 2015 YTD: 18

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.